Work with thought leaders and academic experts in pharmacology medical

Companies can greatly benefit from working with experts in the field of Pharmacology (medical). These researchers possess in-depth knowledge of drug interactions, mechanisms of action, and therapeutic applications. They can provide valuable insights for drug discovery, development, and clinical trials. Additionally, their expertise can help companies navigate regulatory requirements and ensure compliance. Collaborating with Pharmacology (medical) experts can accelerate research and development processes, improve the efficacy and safety of drugs, and ultimately lead to better patient outcomes.

Experts on NotedSource with backgrounds in pharmacology medical include Aimee Eggler, Christos Makridis, Jeffrey Townsend, Jim Samuel, Edoardo Airoldi, Ryan Howell, Emmanouil Mentzakis, Scott Baker, Konstantinos Tsavdaridis, Ashley Hodgson, Tensie Whelan, Martin Brauch, Brian Bushee, Tim Leung, John Shim, David Blanchett, Mark Ryan, Anna Jobin, Catherine Tucker, Wesley R. Hartmann, Sridhar Narayanan, Anindya Ghose, Jennifer Aaker, Melinda Haughey, Ariel Kalil, Dan Baack, Craig Hawker, Norman Farb, Laura Jackson Young, Lea-Rachel Kosnik, Luke Connelly, Roger Sparks, Nora S Vyas, Ph.D., Fadhel Kaboub, Panos Ipeirotis, Prithwiraj Choudhury, Jiang Wang, Emily Owens, Marina Baretti, Miguel Ramirez, Abiodun Adewuya, Peter Reich, Professor Sinead McGilloway, Nam Vu, Laurence Steinberg, Christophe Schinckus, Sheraz Ch, Y. Natalia Alfonso, Orgul Ozturk, Leshui He, Hendrik Wolff, Marian Rizov, Ralf Hepp, Paul Schrater, Gianfranco Santovito, Mehrdad Sheikhvatan, Forough Jahanbazi, Mohamad Shaaf, PhD, andrea bazzani, Dennis Nsafoah, and John Joe.

Christos Makridis

Nashville, TN
Web3 and Labor Economist in Academia, Entrepreneurship, and Policy
Most Relevant Research Interests
Other Research Interests (30)
Web3
Crypto
Blockchain
Fine art
Opera
And 25 more
About
Christos A. Makridis holds academic appointments at Columbia Business School, Stanford University, Baylor University, University of Nicosia, and Arizona State University. He is also an adjunct scholar at the Manhattan Institute, senior adviser at Gallup, and senior adviser at the National AI Institute in the Department of Veterans Affairs. Christos is the CEO/co-founder of [Dainamic](https://www.dainamic.ai/), a technology startup working to democratize the use and application of data science and AI techniques for small and mid sized organizations, and CTO/co-founder of [Living Opera](https://www.livingopera.org/), a web3 startup working to bridge classical music and blockchain technologies. Christos previously served on the White House Council of Economic Advisers managing the cybersecurity, technology, and space activities, as a Non-resident Fellow at the Cyber Security Project in the Harvard Kennedy School of Government, as a Digital Fellow at the Initiative at the Digital Economy in the MIT Sloan School of Management, a a Non-resident Research Scientist at Datacamp, and as a Visiting Fellow at the Foundation for Defense of Democracies. Christos’ primary academic research focuses on labor economics, the digital economy, and personal finance and well-being. He has published over 70 peer-reviewed research papers in academic journals and over 170 news articles in the press. Christos earned a Bachelor’s in Economics and Minor in Mathematics at Arizona State University, as well a dual Masters and PhDs in Economics and Management Science & Engineering at Stanford University.

Lea-Rachel Kosnik

Professor of Economics, University of Missouri-St. Louis, a leading expert on hydropower regulation in the U.S., and other energy and environmental issues
Most Relevant Research Interests
Other Research Interests (42)
Environmental Economics
Energy Economics
Environmental Justice
Text/Content Analysis
Public & Regulatory Economics
And 37 more
About
Lea-Rachel Kosnik is a Professor of Economics at the University of Missouri-St. Louis. She received her BA and MA from the University of Michigan, Ann Arbor, and her PhD from the University of California, Los Angeles. Her research focuses on renewable energy and climate change, and she is considered a leading expert on the topic of hydroelectric energy generation in the U.S., and hydropower regulation by the Federal Energy Regulatory Commission. In recent years her research has expanded to include analyses of the academic economics profession itself, including with a focus on gender issues and DEI initiatives. Methodologically, her skill set includes textual analysis and natural language processing, along with traditional econometric techniques. In 2016 she received an honorable mention for article of the year from *Contemporary Economic Policy*, and in 2022 she gave the keynote address to the Illinois Economics Association. Dr. Kosnik is perhaps best known (in a service capacity) as the Association of Environmental and Resource Economist’s (AERE’s) Midwest representative, annually organizing the full track of AERE-sponsored environmental sessions at the Midwest Economic Association meetings. Dr. Kosnik has also served as President, Past-President, and Board Member of the Transportation and Public Utilities Group (TPUG), and as a Department Chair.

Luke Connelly

Professor of Health Economics, The University of Queensland, CBEH
Most Relevant Research Interests
Other Research Interests (53)
Health economics
insurance
Public Health, Environmental and Occupational Health
Safety, Risk, Reliability and Quality
Human Factors and Ergonomics
And 48 more
About
Luke Connelly is Professor of Health Economics at the Centre for the Business and Economics of Health. He also holds a Professorial appointment (part-time) at The University of Bologna, to which he was appointed in 2017 via the Italian “Direct Call” ([link](https://www.unibo.it/sitoweb/luke.connelly/en)) process. In 2019 he was appointed as Honorary Professor at The University of Sydney. His main interests are in health economics and insurance economics and the effects of institutions (including legal constructs) on incentives and behaviour. He has also worked in other fields of applied microeconomics, including education economics and transport economics. His publications include papers in *Review of Income and Wealth*, *Health Economics*, *Journal of Health Economics*, *Journal of Risk and Insurance*, *Geneva Papers on Risk and Insurance*, *Accident Analysis and Prevention*, *Journal of Law and Medicine*, *Journal of Clinical Epidemiology*, *European Journal of Health Economics*, *International Journal of Health Economics and Finance*, *Social Science and Medicine*, *Economic Papers*, *Economic Analysis and Policy*, *Journal of Transport Economics and Policy*, *Labour Economics*, *Economics and Human Biology* as well as in a range of clinical journals, including *Lancet*. Luke has served on a number of public committees including the Medical Services Advisory Committee (MSAC), which advises the Australian Minister for Health on the safety, efficacy, effectiveness, and cost-effectiveness of new and extant listings on Australia's Medicare Benefits Schedule. He has extensive service on other public committees and taskforces as well as extensive teaching and consulting engagements with industry. Over his career he has been a chief investigator on research grants and contracts totalling more than $67m. He is a member of the Editorial Boards of European Journal of Health Economics and the International Journal on Environmental Research and Public Health. He is a member of the International Health Economics Association's Arrow Awards Committee, which awards an annual prize in honour of Nobel Laureate Kenneth Arrow for the best paper in the field. He is currently Guest Editor (with Christophe Courbage) on a Special Issue of the Geneva Papers on Risk and Insurance on Insurance and Emerging Health Risks. His current research interests include health service innovations to improve the health of people with chronic kidney disease(CKD). Ongoing interests include the economics of disability and insurance, compensable injury compensation schemes, and the determinants of health. Luke enjoys and has considerable experience teaching economics and health economics at both the graduate and undergraduate levels. In 2014 he was awarded the School of Economics Distinguished Teaching Award for his teaching on UQ's Master of Health Economics Program. In July 2016 and July 2019 he also taught summer schools in Health Economics and the Economics of Insurance at The University of Lucerne, Switzerland. Over the past 10 years he has been a chief investigator on grants totalling more than $70m.

Marina Baretti

Baltimore, Maryland, United States of America
I am a clinical translational researcher in gastrointestinal (GI) oncology, collaborating closely with laboratory-based researchers to move laboratory findings into patients and to answer important clinical questions.
Most Relevant Research Interests
Other Research Interests (20)
Oncology
Pharmacology (medical)
Pharmacology
Hematology
Gastroenterology
And 15 more
About
Throughout my training, I have been focused toward my ultimate goal of becoming a clinical translational researcher in gastrointestinal (GI) oncology, collaborating closely with laboratory-based researchers to move laboratory findings into patients and to answer important clinical questions. My clinical research is centered on the development of novel agents in GI cancers, with particular interest in combinatorial approaches of epigenetic therapies and immunotherapies combinations. I ran the first phase II study of combination epigenetic therapy and immunotherapy in advanced pancreatic adenocarcinoma and cholangiocarcinoma, working with a collaborative team that incorporates leading experts in cancer immunology, epigenetics and drug development. I was awarded the 2018 ASCO Conquer Cancer Foundation Young Investigator Award for this project.  Together with Dr. Yarchoan, we are running a clinical trial of a novel neoantigen-specific vaccine in combination with immune checkpoint inhibitors for advanced fibrolamellar carcinoma (FLC) (NCT04248569). My laboratory focus has been on developing and validating a preclinical mouse model of FLC to investigate mechanisms underlying FLC pathogenesis, and will become a critical tool for investigating novel therapeutic strategies in FLC.

Miguel Ramirez

Ward S. Curran Distinguished Professor of Economics, Trinity College
Most Relevant Research Interests
Other Research Interests (62)
Foreign Direct Investment
Latin American Economics
Public investment
Marxian economics.
Development
And 57 more
About
Professor Ramirez is a native of Chile and a naturalized U.S. citizen since 1990. He received his Ph.D. in economics from the University of Illinois at Urbana-Champaign in 1984 and has been at Trinity College since 1985. He has held visiting positions at the University of Illinois at Champaign-Urbana (Summer 1991 and 1992), Haverford College (Spring 1992), Vanderbilt University (Spring 1999), and Yale University (Spring 2006). His teaching interests are primarily in the areas of Latin American economic development and international finance and open economy macroeconomics. At the College he usually offers Latin American economic development and Structural Reform in Latin America during the fall term, while international finance and open economy macroeconomics is taught during the spring term. He also teaches a course in Time-Series Analysis every other spring term, with particular emphasis on unit root and cointegration analysis, error correction modeling, and forecasting. Insofar as his research is concerned, it is primarily dedicated to analyzing the challenges and opportunities that Latin American nations face as they attempt to stabilize and reform their economies in an increasingly globalized world. In particular, his work has reviewed and analyzed the impact of IMF-sponsored adjustment and stabilization measures in Argentina, Chile, and Mexico, as well as the mixed success of structural reform programs such as privatization of state-owned firms, deregulation of economic activity, and liberalization of trade and finance. His research has also focused on the economic and institutional determinants of foreign direct investment in Argentina, Chile, and Mexico, as well as the impact of these flows on private capital formation and labor productivity growth in Latin America. Another important focus of his work in recent years has been the growing role of remittance flows in financing private investment spending and boosting economic growth in countries such as Ecuador, the Dominican Republic, El Salvador, Jamaica, and Mexico. Finally, he has published work in the history of economic thought relating to Marx's important analysis of wages and cyclical crises, his theory of absolute and differential ground rent, his analysis of the falling rate of profit, Marx's controversial writings on the so-called Asiatic mode of production, and his conception of capital as a social process.

Professor Sinead McGilloway

Professor of Family and Community Mental Health and Founder Director of the Centre for Mental Health and Community Research (CMHCR), Maynooth University Department of Psychology (THE 2023 ranking: 126-150) and Social Sciences Institute.
Most Relevant Research Interests
Other Research Interests (40)
Education
Public Health, Environmental and Occupational Health
Health Policy
Sociology and Political Science
Social Sciences (miscellaneous)
And 35 more
About
Professor Sinead McGilloway is Professor of Family and Community Mental Health and Founder Director of the *Centre for Mental Health and Community Research* in the Maynooth University Dept of Psychology and Social Sciences Institute ([www.cmhcr.eu](http://www.cmhcr.eu/)). She is a Chartered Psychologist and Chartered Scientist with the British Psychological Society (BPS) and an Associate Fellow of the BPS. She has extensive experience in undertaking engaged policy- and practice-relevant research with a focus on child and adult mental health and well-being (incl. vulnerable/ marginalised groups), early intervention/prevention and service evaluation. She has won significant research funding to date, is widely published and has won a number of awards, including the Lionel Hersov Memorial (Team) Award by the (UK) Association for Child and Adolescent Mental Health (2022), an Irish Research Council Research Ally prize (2022) and Maynooth University Faculty of Social Sciences Research Achievement Award 2021.

Hendrik Wolff

Professor, London School of Economics
Most Relevant Research Interests
Other Research Interests (26)
Economics and Econometrics
Economics and Econometrics
Agricultural and Biological Sciences (miscellaneous)
Management, Monitoring, Policy and Law
Nature and Landscape Conservation
And 21 more
About
Hendrik Wolff is Professor of Environmental Economics at The London School of Economics and Political Science (LSE). * Hendrik's main research is in environmental economics, working at the intersection of transportation, air pollution, energy and health. This includes the economic causes and consequences of air pollution; the ”value of time;” the impact of energy conservation policies on electricity consumption; cost benefit analysis of the clean air act and its effects on health; the interactions between climate, local prices, wages and “quality of life; and the economics of Daylight Saving Time. He also developed new econometric estimators for large supply and demand systems that are used in agriculture and energy. He has conducted research projects in Ecuador, Germany, Mexico, Australia, Bangladesh, Ghana, England, Chile and the United States. Hendrik is a Faculty Affiliate of the UW Center for Studies in Demography and Ecology, an IZA Research Fellow, and a CESIfo Research Network Affiliate. He was a visiting professor at Resources for the Future, as well as at LMU Munich, University of Cologne and at IZA, Bonn. * Hendrik’s work has impact on both academia and policy. He won the 2009 Ralph C d’Arge and Allen V. Kneese Award for Outstanding Publication, which is awarded annually for the Best Paper in Environmental and Resource Economics. His research has led to important policy changes by the United Nations and the World Bank on the measurement of indices (the Human Development Index (HDI) and the Ease of Doing Business Index). His work is discussed on television (e.g., ABC News) and international media (e.g., The Economist, The Wall Street Journal). He has successfully obtained external funding from organizations such as the NSF, as well as CSSS and the Royalty Research Fund. In addition, he has been the chair for PhD students and Honors students, many of whom have won multiple awards. The job placements of Hendrik’s students are detailed in his CV. He has also consulted for the U.S. Department of Energy and for the President of the World Bank on important policy issues related to his research. * Hendrik is the director of [SelfDrivingCities.com](https://www.selfdrivingcities.com/) a research lab that connects academic researchers, government, and industry in the urban mobility space

Example pharmacology medical projects

How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on pharmacology medical?

Drug Discovery and Development

A pharmaceutical company can collaborate with a Pharmacology (medical) expert to identify potential drug targets, design and optimize drug molecules, and evaluate their efficacy and safety. This collaboration can streamline the drug discovery and development process, reducing costs and time to market.

Clinical Trial Design and Analysis

An academic researcher in Pharmacology (medical) can provide expertise in designing and analyzing clinical trials. They can help optimize trial protocols, select appropriate endpoints, and interpret the results. This collaboration can improve the efficiency and reliability of clinical trials, leading to more accurate and meaningful outcomes.

Pharmacovigilance and Drug Safety

Companies can collaborate with Pharmacology (medical) experts to monitor and assess the safety of their drugs. These experts can analyze adverse drug reactions, evaluate drug-drug interactions, and provide recommendations for risk mitigation. This collaboration can ensure the timely detection and management of potential safety issues, enhancing patient safety.

Regulatory Compliance

Pharmacology (medical) experts can assist companies in navigating complex regulatory requirements. They can provide guidance on preclinical and clinical data requirements, help prepare regulatory submissions, and address regulatory queries. This collaboration can ensure compliance with regulatory agencies and expedite the approval process.

Pharmacokinetics and Pharmacodynamics

Collaborating with a Pharmacology (medical) expert can provide valuable insights into the absorption, distribution, metabolism, and excretion of drugs. They can help optimize dosing regimens, predict drug-drug interactions, and assess drug efficacy. This collaboration can improve the therapeutic outcomes and maximize the benefits of drug treatments.